STADA Arzneimittel AG / Key word(s): Miscellaneous 28.02.2014 13:37 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bad Vilbel, February 28, 2014 - Today, on February 28, 2014, the Russian subsidiary of STADA Arzneimittel AG, OAO Nizhpharm, successfully concluded the purchase of the Russian branded product portfolio Aqualor(R) (see ad hoc release of October 18, 2013 on the signing of the framework agreement for the purchase). The branded product portfolio will be consolidated in the STADA Group as of March 1, 2014. Additional information: STADA Arzneimittel AG / Corporate Communications / StadastraÃe 2-18 / 61118 Bad Vilbel - Germany / Phone: +49(0) 6101 603-113 / Fax: +49(0) 6101 603-506 / E-Mail: communications@stada.de / Or visit us in the Internet at www.stada.com 28.02.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Germany Phone: +49 (0)6101 603- 113 Fax: +49 (0)6101 603- 506 E-mail: communications@stada.de Internet: www.stada.de ISIN: DE0007251803, DE0007251845, WKN: 725180, 725184, Indices: MDAX Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: STADA Arzneimittel AG: Successfully concluded purchase of the Russian branded product portfolio Aqualor(R) for the self-medication of sinusitis and sore throat
| Source: EQS Group AG